Aspect Biosystems

Aspect Biosystems is a Canadian biotechnology company that develops Bioprinted Tissue Therapeutics designed to replace, repair, or supplement biological function in the body. The company's platform integrates AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials to build allogeneic tissue therapeutics. It partners with pharmaceutical and biotech companies to bring cell therapies to the clinic.

Aspect Biosystems is a Canadian biotechnology company. It was co-founded by Tamer Mohamed, who serves as CEO. The company develops Bioprinted Tissue Therapeutics designed to replace, repair, or supplement biological function in the body. Its platform integrates AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials to build allogeneic tissue therapeutics. The company partners with pharmaceutical and biotech companies to bring cell therapies to the clinic.

1. Aspect Biosystems | Bioprinting Tissue Therapeutics
2. Our Story | Aspect Biosystems